# Zemplar

NDC: 0074-9037
Generic name: Paricalcitol
Labeler / Manufacturer: AbbVie Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, LIQUID FILLED
Routes: ORAL
Marketing started: 20180420

FDA application: NDA021606

## Active ingredients

- PARICALCITOL: 2 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0074-9037"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0074-9037
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1b27c026-2d60-47b4-2a9c-ded1818f21b5